| (Values in U.S. Thousands) | Dec, 2025 | Sep, 2025 | Sep, 2024 | Sep, 2024 | Dec, 2023 |
| Sales | 96,050 | 83,520 | 38,420 | 0 | 0 |
| Sales Growth | +15.00% | +117.39% | unch | unch | unch |
| Net Income | 4,420 | 5,710 | -14,900 | 0 | 0 |
| Net Income Growth | -22.59% | +138.32% | unch | unch | unch |
Billiontoone Inc Cl A (BLLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
BillionToOne Inc. is a molecular diagnostics company. BillionToOne Inc. is based in headquartered in Menlo Park, California.
Fiscal Year End Date: 12/31